Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats

Neuroscience Letters

Volumn 504, Issue 3, 2011, Pages 219-222

  Morris, J K ^a   Seim, N B ^a   Bomhoff, G L ^a   Geiger, P C ^a   Stanford, J A ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

6 Hydroxydopamine; Diabetes; Glucose; Insulin; Parkinson's disease

Indexed keywords

DOPAMINE; INSULIN; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPLETION; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AGING; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; EATING; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; NOREPINEPHRINE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, INBRED F344; SUBSTANTIA NIGRA;

EID: 82455175237     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.027     Document Type: Article

References (22)

1. Ahren B. Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 2000, 43:393-410.
2. Barbeau A., Giguere R., Hardy J. Clinical experience with tolbutamide in Parkinson's disease. L'union Medicale du Canada 1961, 90:147-151.
3. Boyd A.E., Lebovitz H.E., Feldman J.M. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa. The Journal of Clinical Endocrinology and Metabolism 1971, 33:829-837.
4. Gonzalez E., McGraw T.E. Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Molecular Biology of the Cell 2006, 17:4484-4493.
5. Gupte A.A., Bomhoff G.L., Geiger P.C. Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. Journal of Applied Physiology 2008, 105:839-848.
6. Hall W.D. An Overview of the Autonomic Nervous System 1990.
7. Ishihara L., Brayne C. A systematic review of nutritional risk factors of Parkinson's disease. Nutrition Research and Review 2005, 18:259-282.
8. Kim B., van Golen C.M., Feldman E.L. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells. Endocrinology 2005, 146:5350-5357.
9. Lipman I.J., Boykin M.E., Flora R.E. Glucose intolerance in Parkinson's disease. Journal of Chronic Diseases 1974, 27:573-579.
10. Lorefat B., Ganowiak W., Wissing U., Granerus A.K., Unosson M. Food habits and intake of nutrients in elderly patients with Parkinson's disease. Gerontology 2006, 52:160-168.
11. Morris J.K., Bomhoff G.L., Stanford J.A., Geiger P.C. Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high fat diet. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2010, 299(4):R1082-R1090.
12. Morris J.K., Zhang H., Gupte A.A., Bomhoff G.L., Stanford J.A., Geiger P.C. Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease. Brain Research 2008, 1240:185-195.
13. National Research Council Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, D.C.
14. Papapetropoulos S., Ellul J., Argyriou A.A., Talelli P., Chroni E., Papapetropoulos T. The effect of vascular disease on late onset Parkinson's disease. European Journal of Neurology 2004, 11:231-235.
15. Pederson T.M., Kramer D.L., Rondinone C.M. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 2001, 50:24-31.
16. Pressley J.C., Louis E.D., Tang M.X., Cote L., Cohen P.D., Glied S., Mayeux R. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003, 60:87-93.
17. Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. The International Journal of Neuroscience 1993, 69:125-130.
18. Simon K.C., Chen H., Schwarzschild M., Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007, 69:1688-1695.
19. Supiano M.A., Hogikyan R.V., Morrow L.A., Ortiz-Alonso F.J., Herman W.H., Galecki A.T., Halter J.B. Aging and insulin sensitivity: role of blood pressure and sympathetic nervous system activity. Journal of Gerontology 1993, 48:M237-M243.
20. Teff K.L. Visceral nerves: vagal and sympathetic innervation. JPEN. Journal of Parenteral and Enteral Nutrition 2007, 32:569-571.
21. Vanitallie T.B. Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction. Metabolism 2008, 57(Suppl. 2):S50-S55.
22. White M.F. IRS proteins and the common path to diabetes. American Journal of Physiology 2002, 283:E413-E422.